PDCD1 and lung cancer: Several recent studies have shown positive correlations between smoking and PD-L1 expression or PD-1/PD-L1 immune checkpoint inhibitor efficacy and better treatment responses to anti-PD-1/PD-L1 immunotherapy than patients with lung cancer who have never smoked [10].